318 related articles for article (PubMed ID: 33421270)
21. Cationic antimicrobial peptides: alternatives and/or adjuvants to antibiotics active against methicillin-resistant Staphylococcus aureus and multidrug-resistant Pseudomonas aeruginosa.
Geitani R; Ayoub Moubareck C; Touqui L; Karam Sarkis D
BMC Microbiol; 2019 Mar; 19(1):54. PubMed ID: 30849936
[TBL] [Abstract][Full Text] [Related]
22. Vancomycin and piperacillin-tazobactam against methicillin-resistant Staphylococcus aureus and vancomycin-intermediate Staphylococcus aureus in an in vitro pharmacokinetic/pharmacodynamic model.
Dilworth TJ; Leonard SN; Vilay AM; Mercier RC
Clin Ther; 2014 Oct; 36(10):1334-44. PubMed ID: 25066667
[TBL] [Abstract][Full Text] [Related]
23. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1997)].
Ikemoto H; Ito C; Yoshida T; Watanabe K; Mori T; Ohno I; Okada S; Igari J; Arakawa M; Igarashi K; Oguri T; Okada M; Ozaki K; Terai T; Aoki N; Inoue H; Nakadate T; Kitamura N; Sekine O; Suzuki Y; Ando M; Suga M; Sato K; Nakata K; Kusano N
Jpn J Antibiot; 1999 May; 52(5):353-97. PubMed ID: 10480048
[TBL] [Abstract][Full Text] [Related]
24. Emergence of vancomycin-intermediate and -resistant Staphylococcus aureus among methicillin-resistant S. aureus isolated from clinical specimens in the northwest of Iran.
Ghahremani M; Jazani NH; Sharifi Y
J Glob Antimicrob Resist; 2018 Sep; 14():4-9. PubMed ID: 29454049
[TBL] [Abstract][Full Text] [Related]
25. Antibacterial and anti-biofilm activities of thiazolidione derivatives against clinical staphylococcus strains.
Liu H; Zhao Y; Zhao D; Gong T; Wu Y; Han H; Xu T; Peschel A; Han S; Qu D
Emerg Microbes Infect; 2015 Jan; 4(1):e1. PubMed ID: 26038759
[TBL] [Abstract][Full Text] [Related]
26. Detection of vancomycin nonsusceptible strains in clinical isolates of Staphylococcus aureus in northern Iran.
Asadpour L; Ghazanfari N
Int Microbiol; 2019 Dec; 22(4):411-417. PubMed ID: 30811005
[TBL] [Abstract][Full Text] [Related]
27. Determination of antibacterial activity and minimum inhibitory concentration of larval extract of fly via resazurin-based turbidometric assay.
Teh CH; Nazni WA; Nurulhusna AH; Norazah A; Lee HL
BMC Microbiol; 2017 Feb; 17(1):36. PubMed ID: 28209130
[TBL] [Abstract][Full Text] [Related]
28. [Investigation of antibiotic resistance patterns and reduced vancomycin susceptibilities of methicillin-resistant Staphylococcus aureus isolates: a multi-center study].
Çıkman A; Aydın M; Gülhan B; Parlak M; Gültepe B; Kalaycı Y; Bayındır Bilmen F; Solmaz S; Özekinci T
Mikrobiyol Bul; 2015 Apr; 49(2):240-8. PubMed ID: 26167824
[TBL] [Abstract][Full Text] [Related]
29. Synergistic effect of non-steroidal anti-inflammatory drugs (NSAIDs) on antibacterial activity of cefuroxime and chloramphenicol against methicillin-resistant Staphylococcus aureus.
Chan EWL; Yee ZY; Raja I; Yap JKY
J Glob Antimicrob Resist; 2017 Sep; 10():70-74. PubMed ID: 28673701
[TBL] [Abstract][Full Text] [Related]
30. In vitro synergy between cefepime and vancomycin against methicillin-susceptible and -resistant Staphylococcus aureus and Staphylococcus epidermidis.
Lozniewski A; Lion C; Mory F; Weber M
J Antimicrob Chemother; 2001 Jan; 47(1):83-6. PubMed ID: 11152435
[TBL] [Abstract][Full Text] [Related]
31. Molecular Characterization of Methicillin and Vancomycin Resistant
Jahanshahi A; Zeighami H; Haghi F
Microb Drug Resist; 2018 Dec; 24(10):1529-1536. PubMed ID: 29883257
[No Abstract] [Full Text] [Related]
32. In Vitro activity of novel glycopolymer against clinical isolates of multidrug-resistant Staphylococcus aureus.
Narayanaswamy VP; Giatpaiboon SA; Uhrig J; Orwin P; Wiesmann W; Baker SM; Townsend SM
PLoS One; 2018; 13(1):e0191522. PubMed ID: 29342216
[TBL] [Abstract][Full Text] [Related]
33. Vancomycin intermediate resistant
Adeoye-Isijola M; Olajuyigbe O; Adebola K; Coopoosamy R; Afolayan A
Afr Health Sci; 2020 Sep; 20(3):1109-1117. PubMed ID: 33402955
[TBL] [Abstract][Full Text] [Related]
34. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1996)].
Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Shimizu Y; Terai T; Inoue H; Nakadate T; Ito C; Yoshida T; Ohno I; Tanno Y; Arakawa M; Igarashi K; Okada M; Ozaki K; Aoki N; Kitamura N; Sekine O; Suzuki Y; Nakata K; Nakatani T; Inagawa H; Kusano N
Jpn J Antibiot; 1998 Jul; 51(7):437-74. PubMed ID: 9755430
[TBL] [Abstract][Full Text] [Related]
35. [Study of marine actinomycetes isolated from the central coast of Peru and their antibacterial activity against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecalis].
León J; Aponte JJ; Rojas R; Cuadra D; Ayala N; Tomás G; Guerrero M
Rev Peru Med Exp Salud Publica; 2011 Jun; 28(2):237-46. PubMed ID: 21845303
[TBL] [Abstract][Full Text] [Related]
36. In vitro activity of meropenem/piperacillin/tazobactam triple combination therapy against clinical isolates of Staphylococcus aureus, Staphylococcus epidermidis, Staphylococcus pseudintermedius and vancomycin-resistant Enterococcus spp.
Yoneda A; Thänert R; Burnham CD; Dantas G
Int J Antimicrob Agents; 2020 Feb; 55(2):105864. PubMed ID: 31870598
[TBL] [Abstract][Full Text] [Related]
37. Comparative studies of the bactericidal, morphological and post-antibiotic effects of arbekacin and vancomycin against methicillin-resistant Staphylococcus aureus.
Watanabe T; Ohashi K; Matsui K; Kubota T
J Antimicrob Chemother; 1997 Apr; 39(4):471-6. PubMed ID: 9145819
[TBL] [Abstract][Full Text] [Related]
38. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (2005)].
Goto H; Takeda H; Kawai S; Watanabe S; Okazaki M; Shimada K; Nakano K; Yokouchi H; Mori T; Igari J; Oguri T; Yamamoto M; Kudo K; Kobayashi N; Tanaka T; Yoshimura K; Kawabata M; Nakamori Y; Sumitomo M; Inoue H; Nakadate T; Suwabe A; Ashino Y; Aoki N; Honma Y; Suzuki Y; Karasawa Y; Oka M; Kobashi Y; Kohno S; Hirakata Y; Kondou A; Matsuda J; Nakano M; Oikawa S
Jpn J Antibiot; 2008 Aug; 61(4):209-40. PubMed ID: 19024644
[TBL] [Abstract][Full Text] [Related]
39. Comparative analysis of antibiotic and antimicrobial biocide susceptibility data in clinical isolates of methicillin-sensitive Staphylococcus aureus, methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa between 1989 and 2000.
Lambert RJ
J Appl Microbiol; 2004; 97(4):699-711. PubMed ID: 15357719
[TBL] [Abstract][Full Text] [Related]
40. Pharmacodynamic activity of ceftobiprole compared with vancomycin versus methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-intermediate Staphylococcus aureus (VISA) and vancomycin-resistant Staphylococcus aureus (VRSA) using an in vitro model.
Zhanel GG; Voth D; Nichol K; Karlowsky JA; Noreddin AM; Hoban DJ
J Antimicrob Chemother; 2009 Aug; 64(2):364-9. PubMed ID: 19454524
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
